{"AllianceGenome": "3012", "HGNC": "3012", "MIM": "612779", "_id": "1806", "_version": 1, "accession": {"genomic": ["AB162145.1", "AC091608.2", "AC093576.3", "AC099787.2", "AC114878.2", "AC138135.2", "AF140781.1", "AL356457.25", "AL645494.6", "BX908805.1", "CH471097.2", "CP068277.2", "KF454986.1", "KF454987.1", "KF495726.1", "NC_000001.11", "NC_060925.1", "NG_008807.2", "OK480642.1", "OK480643.1", "OK480650.1", "OK480651.1", "U57655.1", "X95670.1"], "protein": ["AAA57474.1", "AAB07049.1", "AAB51366.1", "AAH08379.1", "AAH64027.1", "AAI08743.1", "AAI31778.1", "AAI31779.1", "AAP35386.1", "BAA89789.1", "BAD35129.1", "BAF83906.1", "BAG59923.1", "CAA64973.1", "EAW73002.1", "EAW73003.1", "NP_000101.2", "NP_001153773.1", "Q12882.2", "UDL17982.1", "UDL17983.1", "UDL17984.1", "UDL17985.1", "XP_005270619.2", "XP_006710460.1", "XP_016855996.1", "XP_047304032.1", "XP_047304033.1", "XP_054190775.1", "XP_054190776.1", "XP_054190777.1", "XP_054190778.1"], "rna": ["AB003063.1", "AI124948.1", "AK291217.1", "AK297515.1", "BC008379.1", "BC064027.1", "BC108742.1", "BC131777.1", "BC131778.1", "BT006740.1", "DA721123.1", "NM_000110.4", "NM_001160301.1", "OP794520.1", "U09178.1", "U20938.1", "XM_005270562.3", "XM_006710397.4", "XM_017000507.2", "XM_047448076.1", "XM_047448077.1", "XM_054334800.1", "XM_054334801.1", "XM_054334802.1", "XM_054334803.1", "XR_001737014.2", "XR_008485944.1"], "translation": [{"protein": "NP_001153773.1", "rna": "NM_001160301.1"}, {"protein": "XP_006710460.1", "rna": "XM_006710397.4"}, {"protein": "NP_000101.2", "rna": "NM_000110.4"}, {"protein": "XP_047304032.1", "rna": "XM_047448076.1"}, {"protein": "AAB51366.1", "rna": "U20938.1"}, {"protein": "AAH08379.1", "rna": "BC008379.1"}, {"protein": "XP_054190776.1", "rna": "XM_054334801.1"}, {"protein": "XP_054190777.1", "rna": "XM_054334802.1"}, {"protein": "XP_005270619.2", "rna": "XM_005270562.3"}, {"protein": "AAI08743.1", "rna": "BC108742.1"}, {"protein": "BAA89789.1", "rna": "AB003063.1"}, {"protein": "AAI31778.1", "rna": "BC131777.1"}, {"protein": "AAA57474.1", "rna": "U09178.1"}, {"protein": "AAP35386.1", "rna": "BT006740.1"}, {"protein": "BAG59923.1", "rna": "AK297515.1"}, {"protein": "BAF83906.1", "rna": "AK291217.1"}, {"protein": "XP_054190778.1", "rna": "XM_054334803.1"}, {"protein": "XP_054190775.1", "rna": "XM_054334800.1"}, {"protein": "XP_016855996.1", "rna": "XM_017000507.2"}, {"protein": "AAH64027.1", "rna": "BC064027.1"}, {"protein": "XP_047304033.1", "rna": "XM_047448077.1"}, {"protein": "AAI31779.1", "rna": "BC131778.1"}]}, "alias": ["DHP", "DHPDHASE", "DPD", "DYPD"], "ec": "1.3.1.2", "ensembl": {"gene": "ENSG00000188641", "protein": ["ENSP00000307107", "ENSP00000359211"], "transcript": ["ENST00000306031", "ENST00000370192", "ENST00000460019", "ENST00000474241", "ENST00000646851"], "translation": [{"protein": "ENSP00000359211", "rna": "ENST00000370192"}, {"protein": "ENSP00000307107", "rna": "ENST00000306031"}], "type_of_gene": "protein_coding"}, "entrezgene": "1806", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 37.8877449278, "exp_mis": 323.429086085, "exp_syn": 132.458568077, "lof_z": 2.87869661148935, "mis_z": -1.51138235157703, "mu_lof": 2.58643078598e-06, "mu_mis": 2.84042364817e-05, "mu_syn": 1.119000297e-05, "n_lof": 20.0, "n_mis": 379.0, "n_syn": 145.0, "p_li": 4.18972244079049e-09, "p_null": 0.00301404165110853, "p_rec": 0.996985954159169, "syn_z": -0.675546862770884}, "bp": 3078, "cds_end": 98386478, "cds_start": 97544531, "n_exons": 23, "nonpsych": {"exp_lof": 33.8376529876, "exp_mis": 292.28012882, "exp_syn": 119.433376043, "lof_z": 2.50505391852407, "mis_z": -1.31935870915708, "mu_lof": 2.58643078598e-06, "mu_mis": 2.84042364817e-05, "mu_syn": 1.119000297e-05, "n_lof": 19.0, "n_mis": 337.0, "n_syn": 133.0, "p_li": 5.43800172200594e-09, "p_null": 0.012212750675539, "p_rec": 0.987787243886459, "syn_z": -0.781576657102275}, "nontcga": {"exp_lof": 34.812433244, "exp_mis": 297.510487117, "exp_syn": 121.817596398, "lof_z": 3.31246921064929, "mis_z": -1.37169133559351, "mu_lof": 2.58643078598e-06, "mu_mis": 2.84042364817e-05, "mu_syn": 1.119000297e-05, "n_lof": 15.0, "n_mis": 345.0, "n_syn": 131.0, "p_li": 5.27838690393621e-06, "p_null": 0.000315610436804301, "p_rec": 0.999679111176292, "syn_z": -0.526772963503282}, "transcript": "ENST00000370192.3"}, "exons": [{"cdsend": 97920922, "cdsstart": 97078975, "chr": "1", "position": [[97077743, 97079146], [97082329, 97082470], [97098488, 97098632], [97193068, 97193248], [97234851, 97234994], [97305258, 97305378], [97306176, 97306297], [97373560, 97373644], [97382392, 97382461], [97450058, 97450223], [97515725, 97515941], [97549559, 97549744], [97573759, 97573970], [97593217, 97593387], [97595058, 97595166], [97679094, 97679182], [97691716, 97691798], [97699350, 97699547], [97721509, 97721671], [97740391, 97740479], [97828113, 97828196], [97883263, 97883374], [97920883, 97921034]], "strand": -1, "transcript": "NM_000110", "txend": 97921034, "txstart": 97077743}, {"cdsend": 97920922, "cdsstart": 97720887, "chr": "1", "position": [[97719757, 97720926], [97721509, 97721671], [97740391, 97740479], [97828113, 97828196], [97883263, 97883374], [97920883, 97921059]], "strand": -1, "transcript": "NM_001160301", "txend": 97921059, "txstart": 97719757}], "exons_hg19": [{"cdsend": 98386478, "cdsstart": 97544531, "chr": "1", "position": [[97543299, 97544702], [97547885, 97548026], [97564044, 97564188], [97658624, 97658804], [97700407, 97700550], [97770814, 97770934], [97771732, 97771853], [97839116, 97839200], [97847948, 97848017], [97915614, 97915779], [97981281, 97981497], [98015115, 98015300], [98039315, 98039526], [98058773, 98058943], [98060614, 98060722], [98144650, 98144738], [98157272, 98157354], [98164906, 98165103], [98187065, 98187227], [98205947, 98206035], [98293669, 98293752], [98348819, 98348930], [98386439, 98386590]], "strand": -1, "transcript": "NM_000110", "txend": 98386590, "txstart": 97543299}, {"cdsend": 98386478, "cdsstart": 98186443, "chr": "1", "position": [[98185313, 98186482], [98187065, 98187227], [98205947, 98206035], [98293669, 98293752], [98348819, 98348930], [98386439, 98386615]], "strand": -1, "transcript": "NM_001160301", "txend": 98386615, "txstart": 98185313}], "generif": [{"pubmed": 11267945, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 11555601, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 11862480, "text": "circadian expression seen in leukocytes of healthy subjects, but rhythm disturbed in patients with advanced gastrointestinal carcinomas"}, {"pubmed": 11895907, "text": "DPD deficiency resulting from a compound heterozygote is seen in proband of breast cancer patients"}, {"pubmed": 11988088, "text": "Novel disease-causing mutations in the dihydropyrimidine dehydrogenase gene interpreted by analysis of the three-dimensional protein structure"}, {"pubmed": 11992400, "text": "TK1 gene expression together with TS, TP and DPD gene expression may play important roles in influencing the malignant behavior of epithelial ovarian cancer."}, {"pubmed": 12025228, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 12047484, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12209976, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 12360106, "text": "High prevalence of the IVS14 + 1G>A mutation is found in the gene of patients with severe 5-FU-associated toxicity."}, {"pubmed": 12360106, "text": "Observational study of gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 12576451, "text": "Gene expression is a predictor for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer."}, {"pubmed": 12822071, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 12844478, "text": "A deficiency or mutation in this gene in patients with epithelial neoplasms might be the cause of toxicity when administered 5-FU."}, {"pubmed": 12851836, "text": "The DPYD mutation associated with lack of DPD activity, warrants genetic screening of these mutation before administration 5-FU for cancer patients."}, {"pubmed": 14519634, "text": "TS and DPD quantitation may be helpful to evaluate prognosis of patients receiving adjuvant 5-FU and that patients with high TS and low DPD may benefit from adjuvant 5-FU chemotherapy in colorectal cancer."}, {"pubmed": 14562021, "text": "high orotate phosphoribosyltransferase/dihydropyrimidine dehydrogenase ratio associated with longer survival in colorectal cancer patients treated with fluoropyrimidine-based chemotherapy"}, {"pubmed": 14654904, "text": "DPD expression may function as a marker of DPD activity and may be a prognostic indicator for patients with breast cancer."}, {"pubmed": 14702180, "text": "There is no prognostic significance to DHP mRNA expression in breast neoplasms."}, {"pubmed": 15017333, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 15025795, "text": "Observational study of gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 15069545, "text": "In stages I and II, DPD levels in the tumor specimens tended to be higher in the gastric cancer group than in the colorectal cancer group"}, {"pubmed": 15102667, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 15132136, "text": "Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"}, {"pubmed": 15254700, "text": "Thymidine phosphorylase and dihydropyrimidine dehydrogenase have roles in progression of liver metastasis"}, {"pubmed": 15316940, "text": "DPD in differentiated type malignant tissue was statistically lower than in normal stromal tissue (p < 0.001), but no difference was seen in undifferentiated type cases."}, {"pubmed": 15709212, "text": "Specific genetic polymorphisms in drug metabolizing enzymes (e.g., TPMT, UGT1A1, DPD), drug transporters (MDR1), and drug target enzymes (TS) are associated with clinical outcomes in patients treated with 5-fluorouracil and irinotecan."}, {"pubmed": 15939134, "text": "This rate limiting enzyme of 5-fluorouracil whose activity in mononuclear cells shows circadian variation."}, {"pubmed": 15993511, "text": "thymidylate synthase and dihydropyrimidine dehydrogenase are involved in resistance to 5-fluorouracil in human lung cancer cells"}, {"pubmed": 15999119, "text": "thymidylate synthase and orotate phosphoribosyl transferase, but not dihydropyrimidine dehydrogenase, are more highly expressed in prostate cancer than in benign prostatic hyperplasia"}, {"pubmed": 16021908, "text": "a newly described polymorphism of DPD gene might affect transcription of DPD and influence response to 5-FU"}, {"pubmed": 16132996, "text": "Association of mRNA expresion patterns with tumor stage and suggested new prognostic and predictive markers for patients with colorectal cancer."}, {"pubmed": 16328315, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16361556, "text": "Methylation of the DPYD promoter region is associated with down-regulation of DPD activity in clinical samples and should be considered as a potentially important regulatory mechanism of DPD activity and basis for 5-FU toxicity in cancer patients."}, {"pubmed": 16771603, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16786143, "text": "DPD may have a role in progression of colorectal cancer"}, {"pubmed": 16806531, "text": "Sp1 is a strong activator, while Sp3 by its own is a weak activator of the DPYD promoter."}, {"pubmed": 16820886, "text": "DPD gene silencing is caused by epigenetic modification in biliary tract cancer cellsand has a role in sensitivity to 5-FU treatment"}, {"pubmed": 16969493, "text": "thymidine phosphorylase levels are more elevated relative to dihydropyrimidine dehydrogenase levels in squamous cell carcinoma than in adenocarcinoma"}, {"pubmed": 17000685, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17046731, "text": "A novel mutation 464 T>A was identified in DPYD gene exon 5, resulting in the replacement of leucine 155 by a stop codon in the protein."}, {"pubmed": 17121937, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17165084, "text": "The mutation IVS14 + 1 G > A, DPYD*2A, is the most common mutation associated with DPD deficiency"}, {"pubmed": 17203168, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17203168, "text": "thymidylate synthase and dihydropyrimidine dehydrogenase gene polymorphisms have a role in response and toxicity to capecitabine-raltitrexed treatment in colorectal cancer"}, {"pubmed": 17335544, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17375478, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17375478, "text": "study suggested that the influence of DPYD T85C posed only a limited risk for the six malignancies - esophageal, gastric, colon, lung, breast, and malignant lymphomas"}, {"pubmed": 17377791, "text": "Gene expression may be a response to fluorouracil sensitivity in stomach cancers of different histologic origin."}, {"pubmed": 17397246, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17417073, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17417073, "text": "findings, from Korean patients with colon cancer, suggest that polymorphisms of the DPYD gene are not associated with an increased risk for toxic response to 5-fluorouracil"}, {"pubmed": 17445431, "text": "DPYD*5 gene mutation contributes to reduced DPYD enzyme activity and 5-FU metabolism, which is associated with accumulation of 5-FU and chemotherapeutic toxicity in patients with gastric and colonic carcinoma"}, {"pubmed": 17445431, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17582309, "text": "Detection of DPD deficiency would avoid almost every early acute toxic side-effects of fluropyrimidnine treatment."}, {"pubmed": 17582310, "text": "Assays to detect DPD deficiency should be but are not used as a screening test to prevent 5-FU toxicity in cancer treatment."}, {"pubmed": 17612628, "text": "active transcription machinery for DPYD is present in RKO colorectal cancer cells, but promoter binding of Sp1, a transactivator of DPYD, was inhibited, which on subsequent examination was shown to be associated with dense promoter methylation"}, {"pubmed": 17699798, "text": "Results revealed a disturbed transcription of Per1 during tumor progression, which might be the cause for disrupted daily oscillation of DPD in undifferentiated colon carcinoma cells."}, {"pubmed": 17828463, "text": "Nine novel nonsynonymous DPYD SNPs were found in Japanese associated with a risk for developing a severe or fatal toxicity to 5-FU."}, {"pubmed": 17828463, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17848752, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17848752, "text": "study demonstrated relationship between DPYD gene polymorphism among 75 gastric & colon carcinoma patients & its impact on 5-FU pharmacokinetic & side effects; DPYD*5 gene mutation contributes to reduced DPYD enzyme activity & 5-FU dysmetabolism"}, {"pubmed": 17876700, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 17905396, "text": "12 variants in the DPYD coding region & a new intronic polymorphism IVS 6-29 G>T were detected."}, {"pubmed": 17905396, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 18004243, "text": "dihydropyrimidine dehydrogenase is a promising molecular maker for identifying tumor cells sensitivity in breast cancer patients receiving FU-based chemotherapy"}, {"pubmed": 18225548, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18225548, "text": "The IVS14+1G > A mutation (heterozygous) in the DPYD gene was identified in two healthy subjects in this Turkish population."}, {"pubmed": 18299612, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18347391, "text": "pyrimidine nucleoside phosphorylase/dihydropyrimidine dehydrogenase ratio may be a new prognostic marker in breast cancer"}, {"pubmed": 18443386, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18452418, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18537153, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18619742, "text": "High performance liquid chromatography may be used to screen for DPD deficiency in cancer patients before being treated with 5-fluorouracil."}, {"pubmed": 18705276, "text": "The level of Dihydropyrimidine dehydrogenase mRNA may be affected by the clinicopathological status of patients with cirrhosis."}, {"pubmed": 18937829, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19020767, "text": "head & neck, gastric, colorectal, breast, lung & pancreatic cancer were examined; findings show mRNA expression & protein level of thymidylate synthase, dihydropyrimidine dehydrogenase & orotate phosphoribosyltransferase differed according to cancer type"}, {"pubmed": 19104657, "text": "At least in distinct tumor types, a common DPYD polymorphism strongly contributes to the occurrence of fluoropyrimidine-related drug adverse effects."}, {"pubmed": 19104657, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19154585, "text": "Microsatellite instability was correlated with TS gene expression but not significantly with DPD."}, {"pubmed": 19178088, "text": "Frequency of the 735G --> A mutation of the 5'-splice donor site of intron 14 of the dihydropyrimidine dehydrogenase gene (DPYD) in residents of Novosibirsk region (Russia)"}, {"pubmed": 19178088, "text": "Observational study of genotype prevalence and genetic testing. (HuGE Navigator)"}, {"pubmed": 19288105, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19295264, "text": "recurrence-free survival time curve showed significant differences when stratified by tumor diameter, ER expression, and TS levels, but not by menopausal status, nodal status, surgical method, p53 expression, DPD activity, or HER2 expression"}, {"pubmed": 19296131, "text": "Genomic deletions affect DPYD in 7% of all DPD deficient patients."}, {"pubmed": 19296131, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19343046, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19473056, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19473056, "text": "dihydropyrimidine dehydrogenase gene coding sequence variants is associated with the development of fluoropyrimidine-related toxicity in colorectal cancer."}, {"pubmed": 19530960, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19546880, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 19571608, "text": "compared patient survivals between groups, taking TS and DPD cutoff as median values, high versus low DPD and high versus low TS in the cancerous tissue of pancreatic and biliary tract cancers"}, {"pubmed": 19636001, "text": "Observational study of genotype prevalence, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19724871, "text": "patients who developed distant recurrence of rectal cancer were found to have significantly higher intratumoral thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD) and orotate phosphoribosyl transferase (OPRT)"}, {"pubmed": 19795123, "text": "genetic DPD deficiency accounts for around 19% of cases of severe fluoropyrimidine toxicity."}, {"pubmed": 19822137, "text": "Data report two new DPYD gene variants, of which DPYD c.1796T>C is potentially pathogenic, whereas DPYD IVS14+17A>G is suggested as a variant without clinical significance."}, {"pubmed": 19858398, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19898482, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19956635, "text": "Uncategorized study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20037211, "text": "Observational study of gene-disease association and genetic testing. (HuGE Navigator)"}, {"pubmed": 20157331, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20385995, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20407238, "text": "The DPD level was significantly lower in colonic tumors than in rectal tumors; DPD levels in women were significantly lower than that in men"}, {"pubmed": 20453000, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20507294, "text": "An objective behind the study was to ascertain existence of the IVS14 + 1G A DPYD mutation among the population of Bosnia and Herzegovina"}, {"pubmed": 20507294, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20530282, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20544545, "text": "Dihydropyrimidine dehydrogenase deficiency was caused by a novel genomic deletion c.505_513del of DPYD."}, {"pubmed": 20570913, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20647221, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20647710, "text": "OPRT/dihydropyrimidine dehydrogenase ratio has a relation to cancer staging and survival rate."}, {"pubmed": 20653680, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20665215, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20714149, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20714877, "text": "TYMP and TYMS mRNA and protein expression levels were significantly higher in epithelial ovarian cancer, and DPYD mRNA and protein expression levels were significantly lower."}, {"pubmed": 20803296, "text": "Genomic deletion affecting DPYD and a deep intronic mutation affecting pre-mRNA splicing can cause severe 5FU-associated toxicity."}, {"pubmed": 20809970, "text": "Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer."}, {"pubmed": 20819423, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20819423, "text": "Variants in the dihydropyrimidine dehydrogenase, methylenetetrahydrofolate reductase and thymidylate synthase genes predict early toxicity of 5-fluorouracil in colorectal cancer patients."}, {"pubmed": 20837458, "text": "Thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase play a role in the prognosis of non-small-cell lung cancer."}, {"pubmed": 21057378, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 21111509, "text": "Tumor expression levels of thymidylate synthetase and dihydropyrimidine dehydrogenase are predictive of response to S-1-carboplatin chemotherapy in patients with advanced non-small cell lung cancer"}, {"pubmed": 21114665, "text": "We describe the identification and clinical presentation of 4 individuals from 3 unrelated families with hemizygous deletions involving the DPYD gene at chromosome 1p21.3. All met diagnostic criteria for aautism spectrum disorder with severe speech delay."}, {"pubmed": 21498394, "text": "DPYD IVS14+1G>A and 2846A>T predict for severe toxicity to capecitabine, for which patients require dose reductions."}, {"pubmed": 21612699, "text": "The expression level of DPD was correlated to differentiation levels of pancreatic cancer and TNM staging."}, {"pubmed": 21919605, "text": "Specific combinations of functional polymorphisms in DPYD and TYMS were demonstrated to be associated with DFS and overall survival in patients receiving adjuvant 5-FU-based treatment"}, {"pubmed": 21965773, "text": "This study investigated the expression of TS and DPD in cervical lymph node metastases and its relationship with primary oral squamous cell carcinoma, as well as the interaction between these enzymes and Kangai 1(KAI1/CD82)."}, {"pubmed": 22003227, "text": "Hemizygous deletions of the dihydropyrimidine dehydrogenase (DPYD) locus contribute to intellectual disability phenotypes."}, {"pubmed": 22006578, "text": "High TS and DPD mRNA levels on FFPE specimens may predict distant recurrence of rectal cancer treated with 5-FU-based preoperative CRT followed by surgery."}, {"pubmed": 22143355, "text": "Low DPD mRNA expression was related to macroscopic type and associated with poor prognosis. DPD mRNA expression in tumor cells is suggested to be an important regulator of malignant behavior in IHCC."}, {"pubmed": 22199347, "text": "dihydropyrimidine dehydrogenase has a role in prolonged survival in patients with lung adenocarcinoma treated with 5-fluorouracil"}, {"pubmed": 22270332, "text": "No clear correlation was observed between the dihydropyrimidine dehydrogenase mRNA expression and any clinicopathological variable in gallbladder carcinoma."}, {"pubmed": 22306127, "text": "DPYD gene expression is regulated by miR-27a, miR-27b, miR-134, and miR-582-5p."}, {"pubmed": 22339448, "text": "Profound differences in the elimination of 5-fluorouracil could be detected between DPYD-deficient patients and control patients."}, {"pubmed": 22490566, "text": "Results suggest that polymorphisms of rs1801159 in DPYD may be used as valuable predictors of the response to fluorouracil-based chemotherapy for gastric cancer patients in the Chinese population."}, {"pubmed": 22510597, "text": "The radiosensitizing effect of DPYD depletion plus CPT was the additive effect of DPYD depletion and CPT."}, {"pubmed": 22593457, "text": "mRNA expression of TYMS, DPYD, and TYMP is associated with distinct characteristics and may be useful for predicting survival in patients with stage IV colorectal cancer."}, {"pubmed": 22641663, "text": "The organs in which metastases of colorectal cancer arise may be controlled by the expression of dihydropyrimidine dehydrogenase."}, {"pubmed": 23313143, "text": "Data suggest that upregulation of dihydropyrimidine dehydrogenase (DPD) in liver may be involved in acquired resistance to 5-fluorouracil (5-FU), and DPD inhibitors or increasing 5-FU dosage may overcome 5-FU acquired resistance."}, {"pubmed": 23401991, "text": "More than 30 mutations of DPYD gene have been identified in patients with cancer. A large number of them limits introduction of simple genetic test, which could be used for detection of DPD deficiency."}, {"pubmed": 23588312, "text": "A DPYD variant (Y186C) in individuals of african ancestry is associated with reduced DPD enzyme activity."}, {"pubmed": 23597150, "text": "DPD is involved in the survival of human embryo brain-derived cells in culture. There was a a reversed correlation between the activities of XO and DPD over 12 days under normal conditions as well as in the presence of XO and DPD inhibitors."}, {"pubmed": 23603345, "text": "Mutated DPYD is frequently observed in Caucasian patients who experience toxicities while receiving 5-FU/capecitabine."}, {"pubmed": 23736036, "text": "Variation in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity."}, {"pubmed": 23781135, "text": "data clearly indicated that the T464A and homozygous of the T85C of dihydropyrimidine dehydrogenase are stronger biomarkers to predict the 5-FU toxicity"}, {"pubmed": 23930673, "text": "The results of this meta-analysis confirm clinical validity of DPYD IVS14+1G>A and 2846A>T as risk factors for the development of severe toxicities following fluoropyrimidine treatment."}, {"pubmed": 23942539, "text": "DPYD*5 and 1896 T>C accounted for 29.9% of the occurrences of neutropenia (analysis of variance, P = 0.017)."}, {"pubmed": 23960437, "text": "One nonsynonymous SNP of Dihydropyrimidine dehydrogenase (+199381A > G, Asn151Asp) was predicted to change its polarity of amino acid (Asn, neutral to Asp, negative)."}, {"pubmed": 24104963, "text": "In TNBC, we detected 43 (41%) tumour specimens with genomic deletions and/or duplications within DPYD."}, {"pubmed": 24401318, "text": "Taken together, these results suggest that miR-27a and miR-27b expression may be pharmacologically relevant modulators of Dihydropyrimidine dehydrogenase enzyme function in the liver."}, {"pubmed": 24405586, "text": "High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor and response to chemotherapy."}, {"pubmed": 24455740, "text": "We suggest that a chip including DPYD, TYMS, TYMP, TK1, and TK2 genes is a potential tool to predict response in LARC following fluoropyrimidine-based CCRT."}, {"pubmed": 24590654, "text": "Of 36 previously assessed polymorphisms, only four-TYMS 5'VNTR 2R/3R, TYMS 3'UTR 6bpins-del, DPYD 2846TA, and DPYD *2A-were formally associated with global G3+ toxicity in our analysis. Associations were only present in fluorouracil monotherapy regimens."}, {"pubmed": 24647007, "text": "DPYD harbours rare and common capecitabine toxicity variants"}, {"pubmed": 24648345, "text": "Association between flurouracil toxicity and DPYD missense mutations."}, {"pubmed": 24800948, "text": "Colorectal tumors, deficient in mismatch repair, overexpress thymidylate synthetase and dihydropyrimidine dehydrogenase."}, {"pubmed": 24817302, "text": "In patients with heterozygous DPD IVS14+1 mutation, 5-FU dose should be appropriately reduced according to last plasma concentration to reduce adverse reactions, while the homozygous ones should avoid application of 5-FU and its derivatives."}, {"pubmed": 24923815, "text": "Pre-therapeutic DPYD testing may prevent 20-30% of life-threatening or lethal episodes of fluoropyrimidine toxicity in Caucasian patients"}, {"pubmed": 25066213, "text": "genome-wide association studies in women of European ancestry: Data confirm that SNPs in DPYD (rs11587873, rs828054) are associated with ovarian carcinoma; analyses included over 36,000 women contributing DNA in the Ovarian Cancer Assoc Consortium."}, {"pubmed": 25112781, "text": "The expression of dihydropyrimidine dehydrogenase and its correlation with survival in stage II/III gastric cancer patients"}, {"pubmed": 25410891, "text": "results suggest that the baseline 5,6-dihydrouracil:uracil plasma ratio in most individuals reflects the nonsaturated state of DPD and is not predictive of decreased DPD activity"}, {"pubmed": 25677447, "text": "Germline polymorphism of DPYD have a significant effect on toxicity and clinical outcome in patients receiving capecitabine-based chemotherapy for metastatic gastrointestinal malignancies."}, {"pubmed": 25782327, "text": "Single nucleotide polymorphisms (SNPs) in Dihydropyrimidine Dehydrogenase and UGT1A1 influence fluoropyrimdines and irinotecan adverse events (AEs)."}, {"pubmed": 25873402, "text": "miR-494 is directly bound to DPYD 3'UTR and negatively regulated DPYD expression in colon cancer."}, {"pubmed": 25906447, "text": "The dihydropyrimidine dehydrogenase and ERCC1 expression profile could potentially serve as a useful prognostic biomarker and therapeutic target for surgically resected patients with ampullary carcinoma."}, {"pubmed": 26216193, "text": "Reprot strong functional effect of a DPYD haplotype upon a phenotypic marker of individual 5-FU metabolism to improve toxicity prediction."}, {"pubmed": 26265035, "text": "The relationship between DPD genotype and dihydrouracil/uracil values in the 22 patients of the present study was significant"}, {"pubmed": 26265346, "text": "We propose the gene activity score for translating DPYD genotype into phenotype--{REVIEW}"}, {"pubmed": 26281864, "text": "Demonstrate a correlation between occurrence of DPYD gene variant c.496A>G and KRAS wild type status of colorectal cancer tissue."}, {"pubmed": 26372896, "text": "oxaliplatin-based chemotherapy increases ERCC1 and DPYD expression levels; bevacizumab induces VEGFA expression in metastatic colorectal cancer"}, {"pubmed": 26603945, "text": "DPYD variants c.1679T>G and c.1236G>A/HapB3 are clinically relevant predictors of fluoropyrimidine-associated toxicity."}, {"pubmed": 26609109, "text": "Study shows that somatic mutations of DPYD cause a switch in pyrimidine metabolism and promote gene expression of pyrimidine enzymes toward malignant progression."}, {"pubmed": 26658227, "text": "Results suggest that DPYD c.1129-5923 C>G/hapB3 have limited predictive value for severe toxicity to 5-FU based combination chemotherapy."}, {"pubmed": 26804235, "text": "This study demonstrates the clinical validity of combined MIR27A/DPYD screening to identify patients at risk of severe FP-toxicity."}, {"pubmed": 26804652, "text": "Phenotypic and clinical implications of variants in the dihydropyrimidine dehydrogenase gene."}, {"pubmed": 26846104, "text": "Our results revealed that the C allele of the DPYD 85T > C polymorphism might be associated with susceptibility to pediatric acute lymphoblastic leukemia"}, {"pubmed": 27072236, "text": "There were not statistical significant differences between carriers of KRAS mutated alleles between SD and PD groups. No significant difference was found between response rates and toxicity and DPD or UGT1A1 genotypes. Our results suggested that determination of DPD or UGT1A1 genotypes could not be useful for predicting severe toxicity of irinotecan in our population."}, {"pubmed": 27127154, "text": "Increases in gene expression levels of TYMP, DPYD, and HIF1A in tumor tissues at 7 days after the start of CRT may be useful for predicting the efficacy of CRT including S-1 or UFT"}, {"pubmed": 27181275, "text": "Fourteen out of 275 cancer patients (5.1%) carried a DPYD variant and received a 25-50% dose reduction recommendation for 5-fluorouracil or capecitabine. None of the patients with a DPYD variant treated with a reduced dose developed toxicities."}, {"pubmed": 27248859, "text": "We demonstrated that real-time DPYD genotyping using TaqMan probes is cost effective in all fluoropyrimidine-based treatments"}, {"pubmed": 27268079, "text": "Results have shown crosstalk among the EGFR cascade and Sp1 and DPD expressions in EGFR mutant non-small-cell lung cancer cell lines. EGF-induced Sp1 up-regulation resulted in both DPYD mRNA and DPD protein expressions."}, {"pubmed": 27281624, "text": "we believe that developing functional testing at the bedside could probably help to better picture the actual DPD status of patients scheduled for fluorouracil-based therapy, so as to propose subsequent appropriate adaptive dosing strategies."}, {"pubmed": 27399164, "text": "DPYD genotyping for alleles 7, *2A, *13 and Y186C was not helpful in the identification of patients with severe DPD deficiency in this series of patients"}, {"pubmed": 27461651, "text": "findings showed that almost 57.1% of Chinese colorectal cancer patients had at least one variant of DPYD*5A and DPYD*9A"}, {"pubmed": 27727460, "text": "this study was to identify potential risk variants in DPYP gene in an understudied East African population as predictors of severe adverse toxicity to 5-FU"}, {"pubmed": 27741011, "text": "ERCC1-SNP in combination with mRNA ERCC1, DPYD, and ERBB2 from pretherapeutic endoscopic biopsies can predict minor response to chemoradiation, as a basis for individualized therapy of advanced esophageal cancer."}, {"pubmed": 28024938, "text": "This study reports novel and rare genetic variants underlying DPD deficiency in 9 cancer patients presenting with severe fluoropyrimidine-associated toxicity."}, {"pubmed": 28027897, "text": "In pancreatic neuroendocrine neoplasms, biochemical response (p = 0.005) and high dihydropyrimidine-dehydrogenase expression (p = 0.018) were predictive markers of response to 5-FU-based chemotherapy. Thymidylate-Synthase deficiency was an independent risk factor for shorter progression-free survival."}, {"pubmed": 28255193, "text": "High levels of intratumoral DPD expression have a negative impact on sensitivity to 5-fluorouracil in gastric cancer patients, but no prognostic value for long-term survival was uncovered. (Meta-analysis)"}, {"pubmed": 28476815, "text": "Combined expression analyses of hENT1, TS, and DPD may predict long-term outcomes in patients with borderline resectable pancreatic cancer after neoadjuvant chemoradiotherapy"}, {"pubmed": 28481884, "text": "Exploring an extended set of deleterious DPYD variants improves the performance of DPYD genotyping for predicting both grade 3-4 and grade 4 toxicities (digestive and/or neurologic and/or hematotoxicities) related to capecitabine, as compared to conventional genotyping restricted to consensual variants *2A, *13 and D949V"}, {"pubmed": 28603180, "text": "Intratumoral DPD mRNA levels were decreased in extramammary Paget's disease compared to those in normal skin."}, {"pubmed": 28614820, "text": "Carriers of the rare allelic variants DPYD*2A, DPYD*13, and DPYD D949V are more likely to experience severe adverse reactions during fluoropyrimidine-based therapy."}, {"pubmed": 28637434, "text": "Results still showed UGT1A1*6 and UGT1A1*28 to be partially associated with irinotecan-induced toxicity and clinical response. An examination of more UGT1A loci, except for UGT1A1*6 and UGT1A1*28, was not helpful to improve the predictive value of irinotecan-based toxicity and efficacy. An examination of DPYD*5 assisted in the prediction of severe diarrhea."}, {"pubmed": 28929491, "text": "Low DPYD expression is associated with colorectal cancer."}, {"pubmed": 29065426, "text": "*6 rs1801160 and *2A rs3918290 DPYD variant alleles were significantly associated with time to neutropenia in colon cancer."}, {"pubmed": 29134491, "text": "DPYD*2A and MTHFR C677T polymorphisms could explain 5-FU toxicity or clinical outcome in Bangladeshi colorectal patients"}, {"pubmed": 29358721, "text": "DPYD expression was positively associated with aggressive tumor characteristics."}, {"pubmed": 29372689, "text": "The present study suggests that the SNP rs1801160 and the \"IISt\" haplotype in the DPYD gene may also have a role in colorectal cancer risk."}, {"pubmed": 29515256, "text": "DPD tumour expression was a negative prognostic biomarker. Together with tumour expression of hENT1, DPD tumour expression defined patient subgroups that might benefit from either postoperative 5FU/FA or gemcitabine."}, {"pubmed": 29691939, "text": "Whole exome and mitochondrial DNA analyses for the mother and daughter did not reveal additional mutated genes of significance. Thus, an inversion in DPYD should be considered in patients with an inconclusive genotype or unusual clinical phenotype."}, {"pubmed": 29906295, "text": "TYMS 2R3R polymorphism and the -[IVS]14+1G>A mutation in DPYD was not associated with susceptibility to CRC. However, the 2R/2R and 2R/3R genotypes of TYMS polymorphism could significantly contribute to hematological and gastric toxicity in CRC patients in this sample populatio"}, {"pubmed": 30114658, "text": "Data suggest that both common and rare DPYD variants may be associated with toxicity to fluoropyrimidine-based chemotherapy in colorectal cancer patients."}, {"pubmed": 30226808, "text": "the results of the study provided evidence emphasizing the distinct antitumor ability of LINC00261 in cases of esophageal cancer, which was manifested by overexpression of LINC00261 detected to increase the sensitivity of human esophageal cancer cells to 5-FU by mediating methylation-dependent repression of DPYD."}, {"pubmed": 30746637, "text": "Prospective DPYD genotyping can be successfully implemented in routine clinical practice and can reduce the risk of severe fluoropyrimidine toxicities"}, {"pubmed": 30803213, "text": "High expression of DPD is associated with resistance of 5-Fluorouracil in Oral Squamous Cell Carcinoma."}, {"pubmed": 31160238, "text": "In updated analysis of cohort of patients with gastrointestinal malignancies treated with fluoropyrimidines, the prevalence of heterozygous and homozygous DPYD*9A genotypes were 41% and 10%, respectively. The correlation between DPYD*9A genotype and dihydropyrimidine dehydrogenase deficiency clinical phenotype was not reproduced. Previously reported correlation is likely because of small sample size and selection bias."}, {"pubmed": 31653159, "text": "A significant association was observed between DPYD*9A polymorphism and apecitabine and Oxaliplatin (CAPOX) associated toxicities in colorectal cancer patients."}, {"pubmed": 31871216, "text": "Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant."}, {"pubmed": 32529295, "text": "New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine."}, {"pubmed": 32546132, "text": "Evaluation of adverse effects of chemotherapy regimens of 5-fluoropyrimidines derivatives and their association with DPYD polymorphisms in colorectal cancer patients."}, {"pubmed": 32966231, "text": "Genetic influence of DPYD*9A polymorphism on plasma levels of 5-fluorouracil and subsequent toxicity after oral administration of capecitabine in colorectal cancer patients of South Indian origin."}, {"pubmed": 33305610, "text": "Case report: severe toxicity in an African-American patient receiving FOLFOX carrying uncommon allelic variants in DPYD."}, {"pubmed": 33410339, "text": "Patients carrying DPYD variant alleles have increased risk of severe toxicity and related treatment modifications during fluoropyrimidine chemotherapy."}, {"pubmed": 33640964, "text": "DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer."}, {"pubmed": 33877893, "text": "DPYD c.1905 + 1G>A Promotes Fluoropyrimidine-Induced Anemia, a Prognostic Factor in Disease-Free Survival, in Colorectal Cancer."}, {"pubmed": 34484488, "text": "DPYD Genotyping in Patients Who Have Planned Cancer Treatment With Fluoropyrimidines: A Health Technology Assessment."}, {"pubmed": 34612540, "text": "Dihydropyrimidine dehydrogenase (DPYD) gene c.1627A>G A/G and G/G genotypes are risk factors for lymph node metastasis and distant metastasis of colorectal cancer."}, {"pubmed": 34773566, "text": "Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines."}, {"pubmed": 35345374, "text": "Nucleic Acid Metabolizing Enzyme Levels Predict Chemotherapy Effects in Advanced and Recurrent Colorectal Cancer."}, {"pubmed": 35379107, "text": "Frequency and clinical relevance of DPYD genetic variants in gastrointestinal cancer patients.\", trans \"Frecuencia y relevancia clinica de las variantes del gen DPYD en pacientes con tumores digestivos."}, {"pubmed": 35862869, "text": "DPYD*7 as a Predictor of Severe Fluoropyrimidine-Related Adverse Events."}, {"pubmed": 35880438, "text": "Investigation of DPYD, MTHFR and TYMS polymorphisms on 5-fluorouracil related toxicities in colorectal cancer."}, {"pubmed": 36137946, "text": "DPYD and TYMS polymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients."}, {"pubmed": 36172669, "text": "Pharmacogenetic Study of the Dihydropyridine Dehydrogenase Gene in Jordanian Patients with Colorectal Cancer."}, {"pubmed": 36256873, "text": "Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD-genotype variants and P-uracil concentrations."}, {"pubmed": 36357798, "text": "Fluoropyrimidine-associated toxicity and DPYD variants c.85T>C, c.496A>G, and c.1236G>A: impact of haplotype."}, {"pubmed": 36524458, "text": "Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine-induced toxicity in an Asian population."}, {"pubmed": 36661700, "text": "DPYD Exon 4 Deletion Associated with Fluoropyrimidine Toxicity and Importance of Copy Number Variation."}, {"pubmed": 36757428, "text": "Dihydropyrimidine dehydrogenase phenotype in peripheral blood mononuclear cells is related to adverse events of fluoropyrimidine-therapy."}, {"pubmed": 37014829, "text": "Allelic Frequency of DPYD Genetic Variants in Patients With Cancer in Spain: The PhotoDPYD Study."}, {"pubmed": 37267808, "text": "Impact of renal impairment on dihydropyrimidine dehydrogenase (DPD) phenotyping."}, {"pubmed": 37686089, "text": "Genetic Variation in miR-27a Is Associated with Fluoropyrimidine-Associated Toxicity in Patients with Dihydropyrimidine Dehydrogenase Variants after Genotype-Guided Dose Reduction."}, {"pubmed": 38215018, "text": "Common dihydropyrimidinase (DPYS) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort."}, {"pubmed": 38216550, "text": "Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity."}, {"pubmed": 38353109, "text": "MIR27A rs895819 TC genotype increases risk of fluoropyrimidine-induced severe toxicity independently of DPYD variations."}, {"pubmed": 38686795, "text": "Germline cis variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD)."}, {"pubmed": 38709992, "text": "Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare DPYD Variants."}], "genomic_pos": {"chr": "1", "end": 97995000, "ensemblgene": "ENSG00000188641", "start": 97077743, "strand": -1}, "genomic_pos_hg19": {"chr": "1", "end": 98386605, "start": 97543299, "strand": -1}, "go": {"BP": [{"evidence": "IMP", "gocategory": "BP", "id": "GO:0006145", "pubmed": 11988088, "qualifier": "involved_in", "term": "purine nucleobase catabolic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006208", "pubmed": 11988088, "qualifier": "involved_in", "term": "pyrimidine nucleobase catabolic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0006208", "qualifier": "involved_in", "term": "pyrimidine nucleobase catabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006210", "qualifier": "involved_in", "term": "thymine catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006210", "pubmed": 10410956, "qualifier": "involved_in", "term": "thymine catabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006212", "qualifier": "involved_in", "term": "uracil catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006212", "pubmed": [1512248, 18075467], "qualifier": "involved_in", "term": "uracil catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006214", "pubmed": 1512248, "qualifier": "involved_in", "term": "thymidine catabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006248", "qualifier": "involved_in", "term": "CMP catabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006249", "qualifier": "involved_in", "term": "dCMP catabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0019483", "qualifier": "involved_in", "term": "beta-alanine biosynthetic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0046050", "qualifier": "involved_in", "term": "UMP catabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0046079", "qualifier": "involved_in", "term": "dUMP catabolic process"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": 1512248, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "is_active_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "pubmed": 9348115, "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0002058", "qualifier": "enables", "term": "uracil binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 25416956, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0017113", "qualifier": "enables", "term": "dihydropyrimidine dehydrogenase (NADP+) activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0017113", "pubmed": [1512248, 10410956, 18075467], "qualifier": "enables", "term": "dihydropyrimidine dehydrogenase (NADP+) activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0017113", "pubmed": 11988088, "qualifier": "enables", "term": "dihydropyrimidine dehydrogenase (NADP+) activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0017113", "qualifier": "enables", "term": "dihydropyrimidine dehydrogenase (NADP+) activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0042803", "pubmed": 1512248, "qualifier": "enables", "term": "protein homodimerization activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0042803", "qualifier": "enables", "term": "protein homodimerization activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0050660", "qualifier": "enables", "term": "flavin adenine dinucleotide binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0050661", "qualifier": "enables", "term": "NADP binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0050661", "qualifier": "enables", "term": "NADP binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0051539", "qualifier": "enables", "term": "4 iron, 4 sulfur cluster binding"}]}, "homologene": {"genes": [[6239, 180818], [7165, 1270511], [7227, 31858], [7955, 405829], [8364, 734021], [9031, 429083], [9544, 715672], [9598, 457047], [9606, 1806], [9615, 479935], [9913, 281124], [10090, 99586], [10116, 81656]], "id": 85}, "interpro": [{"desc": "Alpha-helical ferredoxin", "id": "IPR009051", "short_desc": "Helical_ferredxn"}, {"desc": "Dihydroprymidine dehydrogenase domain II", "id": "IPR028261", "short_desc": "DPD_II"}, {"desc": "Dihydroorotate dehydrogenase domain", "id": "IPR005720", "short_desc": "Dihydroorotate_DH_dom"}, {"desc": "Aldolase-type TIM barrel", "id": "IPR013785", "short_desc": "Aldolase_TIM"}, {"desc": "4Fe-4S ferredoxin-type, iron-sulphur binding domain", "id": "IPR017896", "short_desc": "4Fe4S_Fe-S-bd"}, {"desc": "4Fe-4S ferredoxin, iron-sulphur binding, conserved site", "id": "IPR017900", "short_desc": "4Fe4S_Fe_S_CS"}, {"desc": "FAD/NAD(P)-binding domain", "id": "IPR023753", "short_desc": "FAD/NAD-binding_dom"}, {"desc": "FAD/NAD(P)-binding domain superfamily", "id": "IPR036188", "short_desc": "FAD/NAD-bd_sf"}], "ipi": ["IPI00029772", "IPI00095889", "IPI00909357"], "map_location": "1p21.3", "name": "dihydropyrimidine dehydrogenase", "other_names": ["dihydropyrimidine dehydrogenase [NADP(+)]", "dihydrothymine dehydrogenase", "dihydrouracil dehydrogenase"], "pantherdb": {"HGNC": "3012", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2139667", "ortholog_type": "LDO", "panther_family": "PTHR43073", "taxid": 10090, "uniprot_kb": "Q8CHR6"}, {"RGD": "621218", "ortholog_type": "LDO", "panther_family": "PTHR43073", "taxid": 10116, "uniprot_kb": "O89000"}, {"Ensembl": "ENSGALG00000005509", "ortholog_type": "LDO", "panther_family": "PTHR43073", "taxid": 9031, "uniprot_kb": "A0A3Q2TU25"}, {"ZFIN": "ZDB-GENE-131121-37", "ortholog_type": "O", "panther_family": "PTHR43073", "taxid": 7955, "uniprot_kb": "A0A0R4IXT5"}, {"ZFIN": "ZDB-GENE-040426-2459", "ortholog_type": "LDO", "panther_family": "PTHR43073", "taxid": 7955, "uniprot_kb": "Q6NYG8"}, {"WormBase": "WBGene00016103", "ortholog_type": "LDO", "panther_family": "PTHR43073", "taxid": 6239, "uniprot_kb": "Q18164"}, {"FlyBase": "FBgn0086450", "ortholog_type": "LDO", "panther_family": "PTHR43073", "taxid": 7227, "uniprot_kb": "Q9W374"}, {"dictyBase": "DDB_G0267966", "ortholog_type": "LDO", "panther_family": "PTHR43073", "taxid": 352472, "uniprot_kb": "Q55FT1"}, {"TAIR": "2088570", "ortholog_type": "LDO", "panther_family": "PTHR43073", "taxid": 3702, "uniprot_kb": "Q9LVI9"}], "uniprot_kb": "Q12882"}, "pathway": {"humancyc": [{"id": "PWY-3982", "name": "uracil degradation"}, {"id": "PWY-6430", "name": "thymine degradation"}, {"id": "PWY-7209", "name": "pyrimidine ribonucleosides degradation"}], "kegg": [{"id": "hsa00240", "name": "Pyrimidine metabolism - Homo sapiens (human)"}, {"id": "hsa00410", "name": "beta-Alanine metabolism - Homo sapiens (human)"}, {"id": "hsa00770", "name": "Pantothenate and CoA biosynthesis - Homo sapiens (human)"}, {"id": "hsa00983", "name": "Drug metabolism - other enzymes - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-15869", "name": "Metabolism of nucleotides"}, {"id": "R-HSA-73621", "name": "Pyrimidine catabolism"}, {"id": "R-HSA-8956319", "name": "Nucleotide catabolism"}], "smpdb": [{"id": "SMP00007", "name": "Beta-Alanine Metabolism"}, {"id": "SMP00046", "name": "Pyrimidine Metabolism"}, {"id": "SMP00172", "name": "Beta Ureidopropionase Deficiency"}, {"id": "SMP00178", "name": "Dihydropyrimidinase Deficiency"}, {"id": "SMP00202", "name": "MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)"}, {"id": "SMP00219", "name": "UMP Synthase Deiciency (Orotic Aciduria)"}, {"id": "SMP00351", "name": "GABA-Transaminase Deficiency"}, {"id": "SMP00492", "name": "Ureidopropionase deficiency"}, {"id": "SMP00493", "name": "Carnosinuria, carnosinemia"}], "wikipathways": [{"id": "WP1601", "name": "Fluoropyrimidine Activity"}, {"id": "WP3945", "name": "TYROBP causal network in microglia"}, {"id": "WP4022", "name": "Pyrimidine metabolism"}]}, "pfam": ["PF01180", "PF07992", "PF14691", "PF14697"], "pharmgkb": "PA145", "pharos": {"target_id": 3898, "tdl": "Tclin"}, "pir": "A54718", "prosite": "PS51379", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF248583", "relationship": "is"}, {"id": "GNF248584", "relationship": "is"}, {"id": "GNF248585", "relationship": "is"}, {"id": "GNF248586", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF156928", "relationship": "is"}, "GNF_hs-Origene": [{"id": "GNF039655", "relationship": "is"}, {"id": "GNF045950", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": {"id": "GNF083698", "relationship": "is"}, "GNF_hs-druggable_plasmid-shRNA": {"id": "GNF073372", "relationship": "is"}, "GNF_hs_LentiORF-HA-MYC": {"id": "GNF282395", "relationship": "is"}, "GNF_hs_LentiORF-Jred": {"id": "GNF283322", "relationship": "is"}, "GNF_mm+hs-MGC": [{"id": "GNF003831", "relationship": "is"}, {"id": "GNF017052", "relationship": "is"}, {"id": "GNF274537", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF234169", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF095177", "relationship": "is"}, {"id": "GNF107427", "relationship": "is"}, {"id": "GNF134834", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_008807.2"], "protein": ["NP_000101.2", "NP_001153773.1", "XP_005270619.2", "XP_006710460.1", "XP_016855996.1", "XP_047304032.1", "XP_047304033.1", "XP_054190775.1", "XP_054190776.1", "XP_054190777.1", "XP_054190778.1"], "rna": ["NM_000110.4", "NM_001160301.1", "XM_005270562.3", "XM_006710397.4", "XM_017000507.2", "XM_047448076.1", "XM_047448077.1", "XM_054334800.1", "XM_054334801.1", "XM_054334802.1", "XM_054334803.1", "XR_001737014.2", "XR_008485944.1"], "translation": [{"protein": "XP_054190778.1", "rna": "XM_054334803.1"}, {"protein": "XP_005270619.2", "rna": "XM_005270562.3"}, {"protein": "XP_054190775.1", "rna": "XM_054334800.1"}, {"protein": "NP_001153773.1", "rna": "NM_001160301.1"}, {"protein": "XP_016855996.1", "rna": "XM_017000507.2"}, {"protein": "XP_006710460.1", "rna": "XM_006710397.4"}, {"protein": "XP_054190776.1", "rna": "XM_054334801.1"}, {"protein": "NP_000101.2", "rna": "NM_000110.4"}, {"protein": "XP_047304033.1", "rna": "XM_047448077.1"}, {"protein": "XP_054190777.1", "rna": "XM_054334802.1"}, {"protein": "XP_047304032.1", "rna": "XM_047448076.1"}]}, "reporter": {"HG-U133_Plus_2": ["1554534_at", "1554536_at", "204646_at"], "HG-U95Av2": "38220_at", "HTA-2_0": "TC01002903.hg.1", "HuEx-1_0": ["2348199", "2424524"], "HuGene-1_1": "7917912", "HuGene-2_1": "16689969"}, "summary": "The protein encoded by this gene is a pyrimidine catabolic enzyme and the initial and rate-limiting factor in the pathway of uracil and thymidine catabolism. Mutations in this gene result in dihydropyrimidine dehydrogenase deficiency, an error in pyrimidine metabolism associated with thymine-uraciluria and an increased risk of toxicity in cancer patients receiving 5-fluorouracil chemotherapy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009].", "symbol": "DPYD", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1366555"}, "unigene": "Hs.335034", "uniprot": {"Swiss-Prot": "Q12882"}, "wikipedia": {"url_stub": "DPYD"}}